View of Cost-effectiveness of two antiviral therapies for chronic hepatitis B in Peru: entecavir and tenofovir

Return to Article Details Cost-effectiveness of two antiviral therapies for chronic hepatitis B in Peru: entecavir and tenofovir Download Download PDF